Publication | Closed Access
Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients.
16
Citations
0
References
1979
Year
Autoimmune DiseaseSclerodermaSystemic Lupus Erythematosus TreatmentLupusSystemic Lupus ErythematosusImmunologyIm PatientsInfectious MononucleosisVirologyAntibody ScreeningAutoimmunityAntiviral ResponseAntibody EngineeringImmunologic DiseaseChronic Viral InfectionImmunotherapyMedicineViral Immunity
Two groups of 22 patients suffering from either systemic lupus erythematosus (SLE) or infectious mononucleosis (IM) were checked for Epstein-Barr virus capsid antigen antibody (EB-VCA) production. The average significant antibody levels as well as the frequency of their occurrence were clearly higher in SLE than in IM patients.